Astonea Labs [ASTONEALAB] vs Entero Healthcare [ENTERO] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 18 vital metrics comparison: Astonea Labs wins in 10 metrics, Entero Healthcare wins in 7 metrics, with 0 ties. Astonea Labs appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricAstonea LabsEntero HealthcareBetter
P/E Ratio (TTM)34.5949.64Astonea Labs
Price-to-Book Ratio7.382.95Entero Healthcare
Debt-to-Equity Ratio289.6721.76Entero Healthcare
PEG RatioN/A1.30N/A
EV/EBITDA12.3926.36Astonea Labs
Profit Margin (TTM)5.49%1.90%Astonea Labs
Operating Margin (TTM)9.43%2.94%Astonea Labs
EBITDA Margin (TTM)9.43%2.94%Astonea Labs
Return on Equity35.35%5.36%Astonea Labs
Return on Assets (TTM)7.29%3.51%Astonea Labs
Free Cash Flow (TTM)$-15.42M$-881.80MAstonea Labs
1-Year Return28.04%-17.14%Astonea Labs
Price-to-Sales Ratio (TTM)1.900.94Entero Healthcare
Enterprise Value$1.89B$51.35BEntero Healthcare
EV/Revenue Ratio1.940.95Entero Healthcare
Gross Profit Margin (TTM)22.53%9.94%Astonea Labs
Revenue per Share (TTM)$126$1,242Entero Healthcare
Earnings per Share (Diluted)$5.09$23.55Entero Healthcare
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Astonea Labs vs Entero Healthcare Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Astonea Labs1.15%0.00%-1.94%22.23%28.89%28.89%
Entero Healthcare1.40%-5.30%-10.01%-2.28%-1.16%-21.13%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Astonea Labs28.04%28.04%28.04%28.04%28.04%28.04%
Entero Healthcare-17.14%-1.50%-1.50%-1.50%-1.50%-1.50%

News Based Sentiment: Astonea Labs vs Entero Healthcare

Astonea Labs

News based Sentiment: MIXED

September presented a mixed bag for Astonea Labs, with leadership changes and fluctuating stock performance occurring alongside a significant shift to a 'very expensive' valuation. While some positive investor participation was observed, the stock's underperformance and valuation concerns create a cautious outlook.

View Astonea Labs News Sentiment Analysis

Entero Healthcare

News based Sentiment: MIXED

Entero Healthcare Solutions is demonstrating strong financial performance with impressive revenue and profit growth, as evidenced by the Q2 FY25 and Q1 FY26 results. However, the stock has experienced significant volatility and a decline over the past six months, creating a mixed investment picture. The upcoming investor meetings and Q3 2026 earnings report will be crucial to watch.

View Entero Healthcare News Sentiment Analysis

Performance & Financial Health Analysis: Astonea Labs vs Entero Healthcare

MetricASTONEALABENTERO
Market Information
Market Cap i₹1.86B₹49.85B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i22,700106,975
90 Day Avg. Volume i25,16783,414
Last Close₹176.00₹1,148.20
52 Week Range₹135.00 - ₹185.00₹1,080.00 - ₹1,584.25
% from 52W High-4.86%-27.52%
All-Time High₹185.00 (Jul 22, 2025)₹1,584.25 (Nov 04, 2024)
% from All-Time High-4.86%-27.52%
Growth Metrics
Quarterly Revenue GrowthN/A0.28%
Quarterly Earnings GrowthN/A0.38%
Financial Health
Profit Margin (TTM) i0.05%0.02%
Operating Margin (TTM) i0.09%0.03%
Return on Equity (TTM) i0.35%0.05%
Debt to Equity (MRQ) i289.6721.76
Cash & Liquidity
Book Value per Share (MRQ)₹23.85₹396.70
Cash per Share (MRQ)₹0.11₹73.09
Operating Cash Flow (TTM) i₹92.50M₹-1,784,990,000
Levered Free Cash Flow (TTM) i₹-124,626,128₹948.20M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Astonea Labs vs Entero Healthcare

MetricASTONEALABENTERO
Price Ratios
P/E Ratio (TTM) i34.5949.64
Forward P/E iN/A22.40
PEG Ratio iN/A1.30
Price to Sales (TTM) i1.900.94
Price to Book (MRQ) i7.382.95
Market Capitalization
Market Capitalization i₹1.86B₹49.85B
Enterprise Value i₹1.89B₹51.35B
Enterprise Value Metrics
Enterprise to Revenue i1.940.95
Enterprise to EBITDA i12.3926.36
Risk & Other Metrics
Beta iN/AN/A
Book Value per Share (MRQ) i₹23.85₹396.70

Financial Statements Comparison: Astonea Labs vs Entero Healthcare

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)ASTONEALABENTERO
Revenue/Sales i₹279.31M₹14.04B
Cost of Goods Sold i₹216.39M₹12.64B
Gross Profit i₹62.91M₹1.40B
Research & Development iN/AN/A
Operating Income (EBIT) i₹26.40M₹412.02M
EBITDA i₹37.02M₹558.96M
Pre-Tax Income i₹17.05M₹363.63M
Income Tax i₹4.58M₹61.31M
Net Income (Profit) i₹12.48M₹302.32M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)ASTONEALABENTERO
Cash & Equivalents i₹881,000₹2.29B
Total Current Assets i₹708.50M₹20.76B
Total Current Liabilities i₹629.45M₹8.45B
Long-Term Debt i₹216.62M₹670.18M
Total Shareholders Equity i₹184.13M₹17.70B
Retained Earnings i₹106.92M₹638.28M
Property, Plant & Equipment i₹43.19M₹1.64B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)ASTONEALABENTERO
Operating Cash Flow i₹53.27MN/A
Capital Expenditures i₹-21.82MN/A
Free Cash Flow i₹42.57MN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricASTONEALABENTERO
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i22,700106,975
Average Daily Volume (90 Day) i25,16783,414
Shares Outstanding i10.51M43.51M
Float Shares i1.75M11.24M
% Held by Insiders i0.86%0.63%
% Held by Institutions i0.03%0.21%

Dividend Analysis & Yield Comparison: Astonea Labs vs Entero Healthcare

MetricASTONEALABENTERO
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A